title: Skin lesion's treatment with alfa interferon in a patient with B-CLL.
abstract: Treatment with recombinant alfa-2b-interferon in a patient with advanced B-CLL resulting in complete remission of skin lesions after one month therapy is reported in this paper. Interferon was administered subcutaneously three times weekly. Six months later while the treatment continued, the disease remained stable.
authors.affiliation: Haematology Unit, Medical School, University of Ioannina, Greece.
authors.forename: K
authors.initials: K
authors.lastname: Panteli
authors.forename: K H
authors.initials: KH
authors.lastname: Katsanos
authors.forename: M
authors.initials: M
authors.lastname: Kitsanou
authors.forename: K
authors.initials: K
authors.lastname: Nakou
authors.forename: G
authors.initials: G
authors.lastname: Alexandridis
authors.forename: K L
authors.initials: KL
authors.lastname: Bourantas
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D011994:Recombinant Proteins; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins